The landscape of protein tyrosine phosphatase (Shp2) and cancer
This article by Dr. Hai-Feng Chen et al. is published in Current Pharmaceutical Design, 2018 As the proteomics technology develops ...
This article by Dr. Hai-Feng Chen et al. is published in Current Pharmaceutical Design, 2018 As the proteomics technology develops ...
This article by Dr. Feng Zhu et al. is published in Current Pharmaceutical Design, 2018 In recent years, proteomics research ...
This article by Dr. Fausto Meriggi et al. is published in Reviews on Recent Clinical Trials, Volume 13, Issue 4, ...
New Haven, Conn. -- An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a chronic disease that ...
UMass Amherst researchers study origins of adverse effects AMHERST, Mass. - Results of a new study by neuroscientists at the ...
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant ...
The article by Dr. Geoff H. Werstuck et al. is published in Cardiovascular & Hematological Disorders-Drug Targets, Volume 18, Issue ...
This article by Dr. Dolores Gonzalez Pacanowska et al. is published in Current Medicinal Chemistry, 2018 Kinetoplastid and apicomplexan parasites ...
This article by Dr. Jose Luis Guerrero Orriach et al. is published in Current Medicinal Chemistry, 2018 Many studies have ...
Fourth study published over two-year span that analyzes key leukemia proteinCredit: Northwestern University CHICAGO --- Northwestern Medicine scientists have discovered ...
This article by Dr. Ahmed A. Haroun et al. is published in Current Bioactive Compounds, Volume 14 , Issue 4 ...
New Haven, Conn. -- In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical ...
ESMO Immuno-Oncology Congress, 13-16 December, Geneva, Switzerland Lugano, Switzerland, 19 December 2018 - Anticancer vaccines have gained a new lease ...
Researchers found that widespread, low-intensity use of antibiotics may play more of a role in antibiotic resistance than high-intensity, repeated ...
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.